BOUGHTON MEDICAL GROUP — All Prescriptions & Medications — Page 7
Practice Code: N81034 | CHESTER, CH2 3DP
Showing results 301-350 of 601
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 67 | 10.8K | £19.8K | +37.5% ▲ | |
| Carvedilol | 66 | 4,403 | £155 | -41.8% ▼ |
| Ranolazine | 66 | 6,000 | £1.1K | -61.2% ▼ |
| 66 | 1,440 | £1.9K | +101.0% ▲ | |
| Umeclidinium bromide | 63 | 83 | £2.2K | +2.2% ▲ |
| Fentanyl | 63 | 686 | £2.4K | -38.5% ▼ |
| Calcium carbonate | 63 | 5,572 | £612 | -4.3% ▼ |
| Vitamins caps | 63 | 1,761 | £36 | +14.7% ▲ |
| Bisacodyl | 62 | 2,864 | £267 | -52.7% ▼ |
| 62 | 1,265 | £3.2K | +90.3% ▲ | |
| 62 | 184 | £1.3K | +122.8% ▲ | |
| 62 | 6,757 | £235 | +24.2% ▲ | |
| Dabigatran etexilate | 61 | 6,976 | £5.5K | +17.8% ▲ |
| Bimatoprost | 61 | 531 | £569 | -59.0% ▼ |
| Mefenamic acid | 59 | 5,290 | £1.1K | +30.6% ▲ |
| Mometasone furoate/olopatadine hydrochloride | 59 | 73 | £924 | +443.1% ▲ |
| Peppermint oil | 57 | 5,552 | £813 | -28.4% ▼ |
| Promethazine hydrochloride | 57 | 2,016 | £264 | -84.1% ▼ |
| Oxcarbazepine | 57 | 6,942 | £2.6K | +103.8% ▲ |
| Carbomer 940/980 | 57 | 2,120 | £373 | -62.6% ▼ |
| Light liquid paraffin | 57 | 28.8K | £564 | +67.4% ▲ |
| 57 | 1,670 | £668 | -26.3% ▼ | |
| Naratriptan hydrochloride | 56 | 594 | £356 | +114.2% ▲ |
| Clobazam | 56 | 5,370 | £1.5K | -15.0% ▼ |
| Febuxostat | 56 | 2,674 | £201 | +49.9% ▲ |
| Desmopressin acetate | 54 | 2,487 | £2.9K | +3.5% ▲ |
| 54 | 930 | £611 | +25.3% ▲ | |
| 54 | 6,220 | £1.3K | +109.4% ▲ | |
| Moxonidine | 53 | 1,869 | £306 | -4.8% ▼ |
| Combined ethinylestradiol 20mcg | 53 | 3,516 | £791 | +1.5% vs avg |
| Exemestane | 53 | 2,894 | £489 | +63.1% ▲ |
| Ready to serve 2.4 kcal/ml milkshake lower volume (0913011) | 53 | 231.5K | £3.2K | -57.2% ▼ |
| 52 | 1,810 | £328 | +280.5% ▲ | |
| Rizatriptan | 51 | 396 | £1.1K | -14.2% ▼ |
| Alfuzosin hydrochloride | 51 | 2,988 | £644 | -28.7% ▼ |
| Ursodeoxycholic acid | 50 | 8,852 | £1.7K | -24.5% ▼ |
| Ivermectin | 50 | 2,325 | £1.4K | +135.2% ▲ |
| Amorolfine hydrochloride | 50 | 250 | £304 | +116.5% ▲ |
| 50 | 1,900 | £2.1K | +34.7% ▲ | |
| 49 | 134 | £1.2K | +58.0% ▲ | |
| Olmesartan medoxomil | 46 | 2,016 | £90 | -33.2% ▼ |
| Acetylcysteine | 46 | 1,668 | £492 | -35.7% ▼ |
| Tapentadol | 46 | 1,852 | £1.1K | +11.7% ▲ |
| Insulin detemir | 46 | 184 | £1.5K | -41.3% ▼ |
| Denosumab | 46 | 46 | £8.4K | +69.0% ▲ |
| Leuprorelin acetate | 46 | 47 | £9.2K | -0.7% vs avg |
| Other toiletry preparations | 46 | 26.2K | £432 | +7.7% ▲ |
| Telmisartan | 45 | 2,016 | £273 | -22.4% ▼ |
| Diclofenac sodium | 45 | 3,772 | £419 | -11.4% ▼ |
| 45 | 570 | £1.9K | +46.4% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.